Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors - A behavioral, biochemical and electrophysiological study

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 344, Issue 3, 1991, Pages 263-274

  Svensson, Kjell ^a   Ekman, Agneta ^a   Piercey, Montford F ^b   Hoffmann, William E ^b   Lum, Janet T ^b   Carlsson, Arvid ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b PFIZER INC   (United States)

Author keywords

Dopamine receptors; Ergolines; Intrinsic activity; Partial agonists

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 HYDROXYBENZYLHYDRAZINE; 5 HYDROXYTRYPTOPHAN; ALPHA 2 ADRENERGIC RECEPTOR; APOMORPHINE; DEXAMPHETAMINE; DOPA; DOPAMINE PARTIAL AGONIST; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GAMMA BUTYROLACTONE; HALOPERIDOL; IDAZOXAN; N (2 CHLORO 6 METHYLERGOLIN 8ALPHA YL)PIVALAMIDE; N (2,6 DIMETHYLERGOLIN 8ALPHA YL)PIVALAMIDE; QUINPIROLE; RADIOLIGAND; RESERPINE; SEROTONIN 1A RECEPTOR; TERGURIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BINDING AFFINITY; BRAIN; CONTROLLED STUDY; DOPAMINE METABOLISM; ELECTROPHYSIOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE UNIT ACTIVITY; SUBCUTANEOUS DRUG ADMINISTRATION;

4-BUTYROLACTONE; ANIMAL; BEHAVIOR, ANIMAL; BRAIN; COMPARATIVE STUDY; DOPAMINE; DOPAMINE AGENTS; ERGOLINES; LISURIDE; MALE; MOTOR ACTIVITY; NEURONS; QUINPIROLE; RATS; RATS, INBRED STRAINS; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; RESERPINE; SEROTONIN; SUBSTANTIA NIGRA; TIME FACTORS;

EID: 0025951464     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/BF00182999     Document Type: Article

References (47)

1. Dopamine “autoreceptors”: Pharmacological characterization by microiontophoretic single cell recording studies
2. Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons
3. B-HT920 is a full agonist at both pre- and postsynaptic D-2 dopamine receptors
4. Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively
5. Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxydopamine lesions and by chronic reserpine treatment in rats
6. 8-Hydroxy-2(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist
7. Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity
8. The mechanism of action of neuroleptic drugs
9. Dopamine receptor agonists: Intrinsic activity vs. state of the receptor
10. The intrinsic activity of (−)-3-PPP (preclamol) on pituitary DA receptors in female rats is enhanced following chronic DA depletion
11. Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo
12. Agonist-antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation
13. Dopamine receptor agonists: Mechanism underlying autoreceptor selectivity. I Review of the evidence
14. Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity. II Theoretical considerations
15. (+)- and (−)-3-PPP exhibit different intrinsic activity at striatal dopamine synthesis
16. An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system
17. Pharmacological properties of SDZ 208-912: A potential high potency, non-classical neuroleptic
18. Partial dopamine-agonistic and atypical neuroleptic properties of the amino ergolines SDZ 208-911 and SDZ 208-912
19. D-2 dopamine autoreceptor selective drugs: Do they really exist? (Minireview)
20. Behavioural effects of serotonin agonists and antagonists in the rat and marmoset
21. Thyroxin and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity
22. Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers
23. Inhibitory effects of partial D2 dopamine receptor agonists on the d-amphetamine cue
24. Behavioral correlations of dopamine receptor activation
25. Stimulation of postsynaptic DA2 receptors produce jerks in reserpine-treated rats
26. Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist S K&F 38393
27. Central dopaminergic properties of HW 165 and its enantiomers; Trans-octahydrobenzo(f)quinoline congeners of 3-PPP
28. Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation
29. Depression of dopamine neuron firing rates by the selective dopamine autoreceptor agonists, (−)-3-PPP and (−)-HW165
30. Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions
31. Functional effects of partial D2 dopamine receptor agonists
32. Transdihydrolisuride, a partial dopamine receptor antagonist: Effects on monoamine metabolism
33. Dopamine agonist activity of EMD 23,488
34. Dopaminergic behaviour stereospecifically promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390
35. The effect of the partial dopamine agonist terguride on negative symptoms in schizophrenics
36. Electrophysiological evaluation of a partial agonist of dopamine receptors
37. U-66444B and U-68553B, potent autoreceptor agonists at dopaminergic cell bodies and terminals
38. Neurochemical and functional studies with EMD 23,448, a novel dopamine agonist
39. Simultaneous measurement of 5-hydroxytryptophan and 1-dihydroxyphenylalanine by high performance liquid chromatography with electrochemical detection. Measurement of serotonin and catecholamine turnover in discrete brain regions
40. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
41. (+)-AJ76 and (+)-UH232: Central stimulants acting as preferential dopamine autoreceptor antagonists
42. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic like effects without catalepsy
43. Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors